Search Results

If you make changes to this saved search, you'll find the original and new searches in your account.

Your search filters:

Amarin Corporation plc

Showing 1-10 of about 206 articles.

Amarin Corporation plc

Amarin to Present at the Cantor Global Healthcare Conference

September 27, 2018

Amarin Corporation plc

REDUCE-IT™ Cardiovascular Outcomes Study of Vascepa® (icosapent ethyl) Capsules Met Primary Endpoint

September 24, 2018

Amarin Corporation plc

REDUCE-IT™ Trial Primary Results Accepted for Presentation at 2018 Scientific Sessions of American Heart Association

September 12, 2018

Amarin Corporation plc

Amarin’s REDUCE-IT™ Clinical Study Now Positioned to be Next Large Cardiovascular Outcomes Study to Report Results

August 26, 2018

Amarin Corporation plc

Real-World Data Supports Association Between Elevated Triglyceride Levels and Increased Peripheral Arterial Revascularization in High Risk Statin-Treated Patients

August 25, 2018

Amarin Corporation plc

Amarin Reports Second Quarter 2018 Financial Results and Provides Update on Operations

August 01, 2018

Amarin Corporation plc

Amarin Announces Approval for Vascepa® in United Arab Emirates

July 26, 2018

Amarin Corporation plc

Amarin to Report Second Quarter 2018 Results and Host Conference Call on August 1, 2018

July 24, 2018

Amarin Corporation plc

Amarin Reports Last Patient Study Visit Has Occurred, an Important Step Towards Completion of REDUCE-IT™ Cardiovascular Outcomes Study

June 28, 2018

Amarin Corporation plc

Real-World Data Supports Association Between High Triglyceride Levels and Increased Cardiovascular Events and Healthcare Costs in People with Diabetes Mellitus

June 25, 2018

Showing 1-10 of about 206 articles.

© 2018 GlobeNewswire, Inc. All Rights Reserved.